Results
|
|
81.
|
Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators. [electronic resource] by
- Tcheng, J E
- Harrington, R A
- Kottke-Marchant, K
- Kleiman, N S
- Ellis, S G
- Kereiakes, D J
- Mick, M J
- Navetta, F I
- Smith, J E
- Worley, S J
Producer: 19950504
In:
Circulation vol. 91
Availability: No items available.
|
|
|
82.
|
Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris. [electronic resource] by
- Jackman, J D
- Navetta, F I
- Smith, J E
- Tcheng, J E
- Davidson, C J
- Phillips, H R
- Califf, R M
- Nelson, C L
- Gardner, L H
- Stack, R S
Producer: 19910729
In:
The American journal of cardiology vol. 68
Availability: No items available.
|
|
|
83.
|
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. [electronic resource] by
- Tcheng, J E
- Ellis, S G
- George, B S
- Kereiakes, D J
- Kleiman, N S
- Talley, J D
- Wang, A L
- Weisman, H F
- Califf, R M
- Topol, E J
Producer: 19941110
In:
Circulation vol. 90
Availability: No items available.
|
|
|
84.
|
Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents. [electronic resource] by
- Cohen, M G
- Kong, D F
- Warner, J J
- Wightman, M B
- Greenbaum, A B
- Tcheng, J E
- Peter, R H
- Sketch, M H
- Muhlbaier, L H
- Zidar, J P
Producer: 20000331
In:
The American journal of cardiology vol. 85
Availability: No items available.
|
|
|
85.
|
Efficacy of abciximab readministration in coronary intervention. [electronic resource] by
- Madan, M
- Kereiakes, D J
- Hermiller, J B
- Rund, M M
- Tudor, G
- Anderson, L
- McDonald, M B
- Berkowitz, S D
- Sketch, M H
- Phillips, H R
- Tcheng, J E
Producer: 20000331
In:
The American journal of cardiology vol. 85
Availability: No items available.
|
|
|
86.
|
Restenosis after coronary angioplasty: an overview. [electronic resource] by
- Califf, R M
- Fortin, D F
- Frid, D J
- Harlan, W R
- Ohman, E M
- Bengtson, J R
- Nelson, C L
- Tcheng, J E
- Mark, D B
- Stack, R S
Producer: 19910522
In:
Journal of the American College of Cardiology vol. 17
Availability: No items available.
|
|
|
87.
|
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. [electronic resource] by
- Lincoff, A M
- Mark, D B
- Tcheng, J E
- Califf, R M
- Bala, M V
- Anderson, K M
- Davidson-Ray, L
- Knight, J D
- Cabot, C F
- Topol, E J
Producer: 20010104
In:
Circulation vol. 102
Availability: No items available.
|
|
|
88.
|
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. [electronic resource] by
- Thel, M C
- Califf, R M
- Tardiff, B E
- Gardner, L H
- Sigmon, K N
- Lincoff, A M
- Topol, E J
- Kitt, M M
- Blankenship, J C
- Tcheng, J E
Producer: 20000331
In:
The American journal of cardiology vol. 85
Availability: No items available.
|
|
|
89.
|
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention. [electronic resource] by
- Gilchrist, I C
- O'Shea, J C
- Kosoglou, T
- Jennings, L K
- Lorenz, T J
- Kitt, M M
- Kleiman, N S
- Talley, D
- Aguirre, F
- Davidson, C
- Runyon, J
- Tcheng, J E
Producer: 20010906
In:
Circulation vol. 104
Availability: No items available.
|
|
|
90.
|
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. [electronic resource] by
- Topol, E J
- Ferguson, J J
- Weisman, H F
- Tcheng, J E
- Ellis, S G
- Kleiman, N S
- Ivanhoe, R J
- Wang, A L
- Miller, D P
- Anderson, K M
- Califf, R M
Producer: 19970821
In:
JAMA vol. 278
Availability: No items available.
|
|
|
91.
|
Local delivery of heparin post-PTCA: a multicenter randomized pilot study. [electronic resource] by
- Tanguay, J F
- Cantor, W J
- Krucoff, M W
- Muhlestein, B
- Barsness, G W
- Zidar, J P
- Sketch, M H
- Tcheng, J E
- Phillips, H R
- Stack, R S
- Kaplan, A V
- Ohman, E M
Producer: 20000515
In:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. 49
Availability: No items available.
|
|
|
92.
|
Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. [electronic resource] by
- Lincoff, A M
- LeNarz, L A
- Despotis, G J
- Smith, P K
- Booth, J E
- Raymond, R E
- Sapp, S K
- Cabot, C F
- Tcheng, J E
- Califf, R M
- Effron, M B
- Topol, E J
Producer: 20000927
In:
The Annals of thoracic surgery vol. 70
Availability: No items available.
|
|
|
93.
|
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study). [electronic resource] by
- Tcheng, J E
- Talley, J D
- O'Shea, J C
- Gilchrist, I C
- Kleiman, N S
- Grines, C L
- Davidson, C J
- Lincoff, A M
- Califf, R M
- Jennings, L K
- Kitt, M M
- Lorenz, T J
Producer: 20011207
In:
The American journal of cardiology vol. 88
Availability: No items available.
|
|
|
94.
|
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. [electronic resource] by
- Tardiff, B E
- Califf, R M
- Tcheng, J E
- Lincoff, A M
- Sigmon, K N
- Harrington, R A
- Mahaffey, K W
- Ohman, E M
- Teirstein, P S
- Blankenship, J C
- Kitt, M M
- Topol, E J
Producer: 19990217
In:
Journal of the American College of Cardiology vol. 33
Availability: No items available.
|
|
|
95.
|
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. [electronic resource] by
- Lincoff, A M
- Tcheng, J E
- Califf, R M
- Kereiakes, D J
- Kelly, T A
- Timmis, G C
- Kleiman, N S
- Booth, J E
- Balog, C
- Cabot, C F
- Anderson, K M
- Weisman, H F
- Topol, E J
Producer: 19990430
In:
Circulation vol. 99
Availability: No items available.
|
|
|
96.
|
Abciximab readministration: results of the ReoPro Readministration Registry. [electronic resource] by
- Tcheng, J E
- Kereiakes, D J
- Lincoff, A M
- George, B S
- Kleiman, N S
- Sane, D C
- Cines, D B
- Jordan, R E
- Mascelli, M A
- Langrall, M A
- Damaraju, L
- Schantz, A
- Effron, M B
- Braden, G A
Producer: 20010913
In:
Circulation vol. 104
Availability: No items available.
|
|
|
97.
|
Laser wire for crossing chronic total occlusions: "learning phase" results from the U.S. TOTAL trial. Total Occlusion Trial With Angioplasty by Using a Laser Wire. [electronic resource] by
- Oesterle, S N
- Bittl, J A
- Leon, M B
- Hamburger, J
- Tcheng, J E
- Litvack, F
- Margolis, J
- Gilmore, P
- Madsen, R
- Holmes, D
- Moses, J
- Cohen, H
- King, S
- Brinker, J
- Hale, T
- Geraci, D J
- Kerker, W J
- Popma, J
Producer: 19980818
In:
Catheterization and cardiovascular diagnosis vol. 44
Availability: No items available.
|
|
|
98.
|
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators. [electronic resource] by
- Lincoff, A M
- Tcheng, J E
- Califf, R M
- Bass, T
- Popma, J J
- Teirstein, P S
- Kleiman, N S
- Hattel, L J
- Anderson, H V
- Ferguson, J J
- Cabot, C F
- Anderson, K M
- Berdan, L G
- Musco, M H
- Weisman, H F
- Topol, E J
Producer: 19970227
In:
The American journal of cardiology vol. 79
Availability: No items available.
|
|
|
99.
|
Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. [electronic resource] by
- Mandak, J S
- Blankenship, J C
- Gardner, L H
- Berkowitz, S D
- Aguirre, F V
- Sigmon, K N
- Timmis, G C
- Gilchrist, I C
- McIvor, M
- Resar, J
- Weiner, B H
- George, B S
- Talley, J D
- Lincoff, A M
- Tcheng, J E
- Califf, R M
- Topol, E J
Producer: 19980626
In:
Journal of the American College of Cardiology vol. 31
Availability: No items available.
|
|
|
100.
|
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. [electronic resource] by
- Steinhubl, S R
- Talley, J D
- Braden, G A
- Tcheng, J E
- Casterella, P J
- Moliterno, D J
- Navetta, F I
- Berger, P B
- Popma, J J
- Dangas, G
- Gallo, R
- Sane, D C
- Saucedo, J F
- Jia, G
- Lincoff, A M
- Theroux, P
- Holmes, D R
- Teirstein, P S
- Kereiakes, D J
Producer: 20010719
In:
Circulation vol. 103
Availability: No items available.
|